Select Page

After a postponement due to COVID travel restrictions, EpiVax is pleased to announce new dates for this year’s Amsterdam Immunogenicity & Tolerance Seminar!

The seminar is now a two-day, afternoon-only format. This arrangement leaves mornings free for attendees to network, collaborate in small groups, and enjoy the beautiful city of Amsterdam.

All events will take place at the Hilton Apollolaan. Apollolaan 138, 1077 BG, Amsterdam, Netherlands


Day 1, Thursday, November 4th, 12:00 PM- 6 PM CET (Central European Time)

  • Lunch will be provided from 12-1 PM
  • Seminar talks will go from 1pm -6 PM
  • Cocktail reception from 6 – 8 PM

Day 2, Friday November 5th, 1 PM – 5 PM CET (Central European Time)

  • Lunch will provided from 12-1 PM
  • Seminar talks will go from 1 PM – 5 PM

The seminar will focus on translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.

Interested in attending this free event? Register here! 

We are so excited to return to Amsterdam and meet safely and responsibly with our colleagues for this in-person event. Please note that we will be monitoring the COVID-19 pandemic and travel restrictions, and we will communicate any changes in advance if the events cannot safely take place.

Special Guest Speakers will include:

Annie De Groot, MD
Research Professor, Center for Vaccines and Immunology, University of Georgia
CEO/CSO, EpiVax, Inc.

Amy Rosenberg, MD
Senior Director of Immunology and Protein Therapeutics, EpiVax, Inc.




Interested in presenting at our seminar? Contact

Interested in attending our seminar? Register here!

In the meantime, check out our previous Amsterdam Immunogenicity & Tolerance seminars!

2019 Immunogenicity & Tolerance Seminar

2018 Immunogenicity & Tolerance Seminar

2017 Immunogenicity & Tolerance Seminar

2016 Immunogenicity & Tolerance Seminar